Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2017:2017:8050432.
doi: 10.1155/2017/8050432. Epub 2017 May 30.

Molecular Identification of Aminoglycoside-Modifying Enzymes and Plasmid-Mediated Quinolone Resistance Genes among Klebsiella pneumoniae Clinical Isolates Recovered from Egyptian Patients

Affiliations

Molecular Identification of Aminoglycoside-Modifying Enzymes and Plasmid-Mediated Quinolone Resistance Genes among Klebsiella pneumoniae Clinical Isolates Recovered from Egyptian Patients

Mohamed F El-Badawy et al. Int J Microbiol. 2017.

Abstract

Inappropriate use of antibiotics in clinical settings is thought to have led to the global emergence and spread of multidrug-resistant pathogens. The goal of this study was to investigate the prevalence of genes encoding aminoglycoside resistance and plasmid-mediated quinolone resistance among clinical isolates of Klebsiella pneumoniae. All K. pneumoniae isolates were phenotypically identified using API 20E and then confirmed genotypically through amplification of the specific K. pneumoniae phoE gene. All isolates were genotyped by the enterobacterial repetitive intergenic consensus polymerase chain reaction technique (ERIC-PCR). Antibiotic susceptibility testing was done by a modified Kirby-Bauer method and broth microdilution. All resistant or intermediate-resistant isolates to either gentamicin or amikacin were screened for 7 different genes encoding aminoglycoside-modifying enzymes (AMEs). In addition, all resistant or intermediate-resistant isolates to either ciprofloxacin or levofloxacin were screened for 5 genes encoding the quinolone resistance protein (Qnr), 1 gene encoding quinolone-modifying enzyme, and 3 genes encoding quinolone efflux pumps. Biotyping using API 20E revealed 13 different biotypes. Genotyping demonstrated that all isolates were related to 2 main phylogenetic groups. Susceptibility testing revealed that carbapenems and tigecycline were the most effective agents. Investigation of genes encoding AMEs revealed that acc(6')-Ib was the most prevalent, followed by acc(3')-II, aph(3')-IV, and ant(3'')-I. Examination of genes encoding Qnr proteins demonstrated that qnrB was the most prevalent, followed by qnrS, qnrD, and qnrC. It was found that 61%, 26%, and 12% of quinolone-resistant K. pneumoniae isolates harbored acc(6')-Ib-cr, oqxAB, and qebA, respectively. The current study demonstrated a high prevalence of aminoglycoside and quinolone resistance genes among clinical isolates of K. pneumoniae.

PubMed Disclaimer

Figures

Figure 1
Figure 1
Representative DNA fingerprint pattern of K. pneumoniae clinical isolates genotyped by ERIC-PCR.
Figure 2
Figure 2
Generated UPGMA dendrogram based on Dice similarity coefficient for clustering of K. pneumoniae isolates using ERIC-PCR as DNA fingerprinting method. KL: Klebsiella pneumoniae, PGA: phylogenetic group A, and PGB: phylogenetic group B.
Figure 3
Figure 3
Representative PCR products of detected genes encoding AMEs. Lanes: (1) ant (3′′)-I; (L) 100 bp ladder; (2) armA; (3) acc(6)-Ib; (4) aph(3)-VI; (5) acc(3-)-II.
Figure 4
Figure 4
Representative PCR products of detected quinolone resistance genes. Lanes: (1) qnrB; (2) qnrC; (3) qnrD; (4) qnrS; (L) 100 bp ladder; (5) acc(6)-Ib-cr; (6) oqxA; (7) oqxb; (8) qebA.

Similar articles

Cited by

References

    1. Michalska A. D., Sacha P. T., Kaczyńska K., Tryniszewska E. A. The diversity of aminoglycoside-modifying enzymes among ESBL-positive proteus mirabilis clinical strains. Medtube Science. 2014;4(16):16–20.
    1. Vakulenko S. B., Mobashery S. Versatility of aminoglycosides and prospects for their future. Clinical Microbiology Reviews. 2003;16(3):430–450. doi: 10.1128/CMR.16.3.430-450.2003. - DOI - PMC - PubMed
    1. Ramirez M. S., Tolmasky M. E. Aminoglycoside modifying enzymes. Drug Resistance Updates. 2010;13(6):151–171. doi: 10.1016/j.drup.2010.08.003. - DOI - PMC - PubMed
    1. Soleimani N., Aganj M., Ali L., Shokoohizadeh L., Sakinc T. Frequency distribution of genes encoding aminoglycoside modifying enzymes in uropathogenic E. coli isolated from Iranian hospital. BMC Research Notes. 2014;7(1):p. 842. doi: 10.1186/1756-0500-7-842. - DOI - PMC - PubMed
    1. Guan X., Xue X., Liu Y., et al. Plasmid-mediated quinolone resistance-current knowledge and future perspectives. Journal of International Medical Research. 2013;41(1):20–30. doi: 10.1177/0300060513475965. - DOI - PubMed

LinkOut - more resources